Charles Schwab Investment Management Inc Protara Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 95,774 shares of TARA stock, worth $496,109. This represents 0.0% of its overall portfolio holdings.
Number of Shares
95,774
Previous 15,000
538.49%
Holding current value
$496,109
Previous $63,000
360.32%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding TARA
# of Institutions
86Shares Held
28.1MCall Options Held
37.2KPut Options Held
65.1K-
Janus Henderson Group PLC London, X04.1MShares$21.3 Million0.01% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA2.14MShares$11.1 Million11.14% of portfolio
-
Blackstone Inc New York, NY1.91MShares$9.89 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.8MShares$9.33 Million0.0% of portfolio
-
Acorn Capital Advisors, LLC New York, NY1.75MShares$9.08 Million3.47% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $58.4M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...